A recent meta-analysis explored the efficacy of CoQ 10 on the plasma levels of C-reactive protein, interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-) in patients afflicted with pathologies in which inflammation was a common factor including cardio-cerebral vascular disease, multiple sclerosis, obesity, renal failure, rheumatoid arthritis, diabetes, and fatty liver disease (Fan et al., 10 in doses ranging from 60 to 500 mg/day for a 1-week to 4-month intervention period significantly decreased production of inflammatory cytokines
Future Hopes for Partial Epigenetic Reprogramming Therapies David Sinclair has also said that Life Biosciences is interested in tackling other diseases with their partial epigenetic reprogramming-based gene therapies
Kim BH, Jun YC, Jin JK, Kim JI, Kim NH, Leibold EA, et al
Brown et al., 2016
140ml antioxidant-rich formula reduces dark spots & uneven tone for luminous, youthful skin